Timely Intravenous Magnesium for Asthma in Children
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
Many children currently being hospitalized with severe asthma could potentially avoid
hospitalization and be sent home if their treatment in the emergency department was more
effective. We will conduct a pilot trial that will lead to a larger study to conclusively
answer whether a simple and inexpensive medicine, intravenous magnesium sulfate, can be used
in the emergency department to prevent hospitalization for these children.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Utah
Collaborators:
Children's Hospital of Philadelphia Nationwide Children's Hospital